Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Animal models of Charcot-Marie-Tooth disease and their relevance for understanding the disease in humans.]
Another Case of PML with Gilenya Reported by Novartis
A rare case of nonenhancing primary central nervous system lymphoma mimic multiple sclerosis.
Metabolomics in multiple sclerosis.
Acute disseminated encephalomyelitis: case report and brief review.
The Rao's Brief Repeatable Battery version B: normative values with age, education and gender corrections in an Italian population.
A Limited Form of Neuromyelitis Optica With a Lesion of the Fourth Nerve Nucleus.
Health Care Costs Associated With Geriatric Patients Diagnosed With Multiple Sclerosis Taking Disease Modifying Agents In The United States.
The effect of B-cell depletion in the Theiler's model of multiple sclerosis.
Acute neuronal apoptosis in a rat model of multiple sclerosis.
Intracellular IL-10 detection in T cells by flowcytometry: the use of protein transport inhibitors revisited.
Multiple Sclerosis: Changes in Thalamic Resting-State Functional Connectivity Induced by a Home-based Cognitive Rehabilitation Program.
[Intravenous immunoglobulin in treatment of autoimmune neurological diseases in children].
Eomesodermin Expression in CD4+ T Cells Restricts Peripheral Foxp3 Induction.
DEMYELINATION/REMYELINATION AND EXPRESSION OF INTERLEUKIN-1β, SUBSTANCE P, NERVE GROWTH FACTOR, AND GLIAL-DERIVED NEUROTROPHIC FACTOR DURING TRIGEMINAL NEUROPATHIC PAIN IN RATS.
[Relevance of Magnet Resonance Tomography in the Diagnosis and Assessment of Course of Disease in Patients with Multiple Sclerosis].
Participant recruitment into a randomised controlled trial of exercise therapy for people with multiple sclerosis.
Cost-Effectiveness Analysis of Delayed-Release Dimethyl-Fumarate In The Treatment of Relapsing-Remitting Multiple Sclerosis In Italy.
A Disproportionate Burden of Care: Gender Differences in Mental Health, Health-Related Quality of Life, and Social Support in Mexican Multiple Sclerosis Caregivers.
Self-esteem, social participation, and quality of life in patients with multiple sclerosis.
Impact of Ongoing National Health Technology Assessment Challenges on Patient Access to New Therapies for Multiple Sclerosis In Germany And The Uk.
Sharing data from MS clinical trials: Opportunities, challenges, and future directions.
Axon-to-Glia Interaction Regulates GabaA Receptor Expression in Oligodendrocytes.
Antimalarial Drug Artemether Inhibits Neuroinflammation in BV2 Microglia Through Nrf2-Dependent Mechanisms.
Chronic inflammatory demyelinating polyneuropathy in common variable immunodeficiency.
Pages
« first
‹ previous
…
708
709
710
711
712
713
714
715
716
…
next ›
last »